Plasma pharmacokinetics of midazolam in chickens, turkeys, pheasants and bobwhite quail

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 5, 2007, Pages 429-436

  Cortright, K A ^a,b   Wetzlich, S E ^a   Craigmill, A L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Environmental Toxicology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; MIDAZOLAM;

AREA UNDER THE CURVE; ARTICLE; BOOTSTRAPPING; CHICKEN; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; HALF LIFE TIME; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; QUAIL; TURKEY (BIRD);

ANIMALS; AREA UNDER CURVE; BIRDS; CHICKENS; FEMALE; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; MALE; MIDAZOLAM; QUAIL; TURKEYS;

COLINUS VIRGINIANUS; GALLUS GALLUS; PHASIANIDAE;

EID: 34548413177     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00880.x     Document Type: Article

References (14)

1. Cortright, K.A. Craigmill, A.L. (2006) Cytochrome P450-dependent metabolism of midazolam in hepatic microsomes from chickens, turkeys, pheasant and bobwhite quail. Journal of Veterinary Pharmacology and Therapeutics, 29, 468 476.
2. Day, T.K. Roge, C.K. (1996) Evaluation of sedation in quail induced by use of midazolam and reversed by use of flumazenil. Journal of American Veterinary Medical Association, 209, 969 971.
3. Duval, V. Karlsson, M.O. (2002) Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment model. Pharmaceutical Research, 19, 1835 1840.
4. Ette, E. Williams, P. (2004) Population pharmacokinetics II: estimation methods. The Annals of Pharmacotherapy, 38, 1907 1915.
5. Forbes, N.A. (1998) Avian anesthesia. Veterinary Quarterly, 20, S65 66.
6. Hardman, J.G. (ed. 2001) Goodman & Gilman's the Pharmacological Basis of Therapeutics. McGraw-Hill, New York.
7. Kobayashi, K., Urashima, K., Shimada, N. Chiba, K. (2002) Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochemical Pharmacology, 63, 889 896.
8. Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F.J. Meyer, U.A. (1989) Oxidation of midazolam and triazolam by human liver cytochrome P4503A4. Molecular Pharmaceutics, 36, 89 96.
9. Lindsey, J.K., Jones, B. Jarvis, P. (2001) Some statistical issues in modelling pharmacokinetic data. Statistics in Medicine, 20, 2775 2783.
10. Ma, F. Lau, C.E. (1996) Determination of midazolam and its metabolites in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. Journal of Chromatography B, 682, 109 113.
11. Machin, K.L. Caulkett, N.A. (1998) Investigation of injectable anesthetic agents in Mallard ducks (Anas platyrhynchos): a descriptive study. Journal of Avian Medicine and Surgery, 12, 255 262.
12. Mager, H. Goller, G. (1998) Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies. Journal of Pharmaceutical Sciences, 87, 372 378.
13. Mandema, J.W., Tuk, B., van Steveninck, A.L., Breimer, D.D., Cohen, A.F. Danhof, M. (1992) Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha- hydroxymidazolam in healthy volunteers. Clinical Pharmacology and Therapeutics, 51, 715 728.
14. Vree, T.B., Baars, A.M., Booij, L.H.D. Driessen, J.J. (1981) Simultaneous determination and pharmacokinetics of midazolam and its hydroxymetabolites in plasma and urine of man and dog by means of high-performance liquid chromatography. Arzneim Forsch, 31, 2215 2219.